Full-Time

Associate Director Regulatory Affairs

Confirmed live in the last 24 hours

Becton Dickinson

Becton Dickinson

10,001+ employees

Develops and sells medical devices and diagnostics

Compensation Overview

$169.8k - $280.3k/yr

Senior, Expert

San Diego, CA, USA

4 days in-office at San Diego site, 1 day remote (Friday).

Category
Risk & Compliance
Legal & Compliance
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides
Requirements
  • Bachelor’s degree in a scientific discipline: Engineering, Biology, etc. or equivalent.
  • Minimum 10 years of relevant work experience including experience within the Medical Device industry.
  • Minimum of 5 years of experience in Regulatory Affairs working with complex medical device systems and software strongly preferred.
  • Experience working with external service providers, consultants, and regulators required.
  • Strong project management skills and organizational abilities.
  • Excellent written and verbal communication skills.
  • Proficiency in Microsoft Office Suite, especially Word, Excel, and PowerPoint.
Responsibilities
  • Lead submission activities for various initiatives.
  • Work closely with cross-functional teams on submission strategy and documentation development for new product submissions.
  • Coordinate interactions between internal stakeholders and external service providers to ensure timely completion of submission milestones.
  • Assist in the maintenance of departmental systems used to track projects and ongoing operational activities.
  • Directly interface with regulators as needed.
  • Perform additional tasks as required.
Desired Qualifications
  • Advanced degree (Master’s degree or higher) preferred.
  • Regulatory Affairs Certification (RAC) preferred.
  • Project Management Certification preferred.
  • Familiarity with Infusion Pump Systems preferred.

BD (Becton, Dickinson and Company) focuses on improving health through medical technology. The company operates in three main areas: BD Medical, BD Life Sciences, and BD Interventional, each targeting different healthcare needs. BD develops, manufactures, and sells medical devices, laboratory equipment, and diagnostic products to hospitals, laboratories, and healthcare providers worldwide. Their products aim to enhance patient outcomes, reduce healthcare costs, and improve safety and efficiency in medical care. What sets BD apart from competitors is its comprehensive approach to healthcare solutions across various segments, allowing for a wide range of services and products that cater to diverse healthcare challenges. The company's goal is to advance healthcare by providing effective tools and technologies that support better medical discovery and care delivery.

Company Size

10,001+

Company Stage

IPO

Headquarters

Eysins, Switzerland

Founded

1961

Simplify Jobs

Simplify's Take

What believers are saying

  • BD's $1.2B investment boosts syringe manufacturing and drug delivery capabilities.
  • AI integration in healthcare offers BD opportunities to enhance diagnostic accuracy and efficiency.
  • Growing demand for pre-fillable syringes aligns with BD's recent manufacturing investments.

What critics are saying

  • Increased competition in the syringe market may impact BD's market share.
  • Integration of Cubex LLC's assets may challenge BD's operational efficiency.
  • New executive appointments may lead to strategic shifts disrupting current operations.

What makes Becton Dickinson unique

  • BD's global reach spans North America, EMEA, Greater Asia, and Latin America.
  • BD's diverse segments include Medical, Life Sciences, and Interventional, covering various healthcare needs.
  • BD's focus on innovation enhances patient outcomes and operational efficiencies in healthcare.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Tuition Reimbursement

Company News

Slater Sentinel
Jan 4th, 2024
Affinity Wealth Management LLC Invests $2.18 Million in Becton, Dickinson and Company (NYSE:BDX)

Affinity Wealth Management LLC purchased a new stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 8,443 shares of the medical instruments supplier’s stock, valued at approximately $2,183,000. Other […]

PR Newswire
Jul 28th, 2022
BD Acquires MedKeeper to Offer Cloud-based, Connected Pharmacy Software

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired MedKeeper, a...

ROI-NJ
Jul 28th, 2022
Bd Acquires Medkeeper To Offer Cloud-Based, Connected Pharmacy Software

BD on Thursday said it acquired MedKeeper, a provider of modern, cloud-based pharmacy management applications. The acquisition adds to the Franklin Lakes-based company’s recent growth in high-technology pharmacy solutions and further accelerates its commitment to smart, connected care

PR Newswire
Feb 9th, 2022
Day Zero Diagnostics Announces Completion of $21M Financing

/PRNewswire/ -- Day Zero Diagnostics, Inc., an infectious disease diagnostics company harnessing the power of whole-genome sequencing and machine learning to...

PR Newswire
Feb 1st, 2022
BD Expands from Cancer Discovery and Diagnosis into Post-Treatment Monitoring with Acquisition of Cytognos from Vitro S.A.

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition...